awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28077347-BF53FC40-7270-4F16-9A21-84B4ADA33B80
Q28077347-BF53FC40-7270-4F16-9A21-84B4ADA33B80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077347-BF53FC40-7270-4F16-9A21-84B4ADA33B80
FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance
P2860
Q28077347-BF53FC40-7270-4F16-9A21-84B4ADA33B80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077347-BF53FC40-7270-4F16-9A21-84B4ADA33B80
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81e92708a10e9879b2804f2ed10ca9f45ed22e74
P2860
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.